The Antimicrobial Effect of Lactobacillus casei against Klebsiella pneumoniae and Escherichia coli Isolated from Urinary Samples

Publish Year: 1403
نوع سند: مقاله ژورنالی
زبان: English
View: 45

This Paper With 12 Page And PDF Format Ready To Download

  • Certificate
  • من نویسنده این مقاله هستم

استخراج به نرم افزارهای پژوهشی:

لینک ثابت به این Paper:

شناسه ملی سند علمی:

JR_JABS-14-2_002

تاریخ نمایه سازی: 28 مرداد 1403

Abstract:

Background & Objectives: Urinary tract infection (UTI) is a serious issue affecting both men and women resulting from the invasion of microbial agents into the urinary system. This study aimed to investigate the antimicrobial activity of Lactobacillus casei (L. casei) against Klebsiella pneumoniae (K. pneumoniae) and Escherichia coli (E. coli) isolated from UTI. Materials & Methods: In this study, ۱۰۰ urine specimens were obtained from medical laboratories in western Tehran. E. coli and K. pneumoniae isolates were identified and subsequently confirmed using polymerase chain reaction (PCR). Antibiotic susceptibility patterns were determined using the disk diffusion method. The antimicrobial activity of L. casei against these strains (four multidrug-resistant isolates from each species) was then evaluated using the agar well diffusion method. Results: From ۱۰۰ urine specimens, ۷۶ E. coli and ۱۴ K. pneumoniae isolates were identified. Antimicrobial susceptibility testing revealed that imipenem and nitrofurantoin were the most effective antibiotics against E. coli, while amikacin demonstrated the highest efficacy against K. pneumoniae. In the agar well diffusion assay, L. casei generated growth inhibition zones measuring ۱۹.۸ mm ± ۳ for E. coli and ۲۰.۳ mm ± ۴ for K. pneumoniae. Conclusions: Lactobacillus casei demonstrates notable antimicrobial efficacy against both E. coli and K. pneumoniae, suggesting its potential as an alternative therapeutic option for UTIs.

Authors

مژگان فاتح

Department of Microbiology, Shahr-e-Qods Branch, Islamic Azad University, Tehran, Iran

فاطمه فروهی

Department of Microbiology, Shahr-e-Qods Branch, Islamic Azad University, Tehran, Iran

فاطمه رفیعی

Department of Microbiology, Shahr-e-Qods Branch, Islamic Azad University, Tehran, Iran

مراجع و منابع این Paper:

لیست زیر مراجع و منابع استفاده شده در این Paper را نمایش می دهد. این مراجع به صورت کاملا ماشینی و بر اساس هوش مصنوعی استخراج شده اند و لذا ممکن است دارای اشکالاتی باشند که به مرور زمان دقت استخراج این محتوا افزایش می یابد. مراجعی که مقالات مربوط به آنها در سیویلیکا نمایه شده و پیدا شده اند، به خود Paper لینک شده اند :
  • Reid G. Perspective: microbial interventions in the urinary tract. Microbiome ...
  • Shahkolahi S, Shakibnia P, Shahbazi S, Sabzi S, Badmasti F, ...
  • Kim DS, Lee JW. Urinary Tract Infection and Microbiome. Diagnostics. ...
  • Kaur R, Kaur R. Symptoms, risk factors, diagnosis and treatment ...
  • Desie N, Willems A, De Laet I, Dits H, Van ...
  • Singh B, Tilak R, Srivastava R, Katiyar D. Urinary tract ...
  • Shahbazi R, Alebouyeh M, Shahkolahi S, Shahbazi S, Hossainpour H, ...
  • Rahimzadeh M, Shahbazi S, Sabzi S, Habibi M, Asadi Karam ...
  • Soltani N, Abbasi S, Baghaeifar S, Taheri E, Jadid MFS, ...
  • Naderi A, Kasra-Kermanshahi R, Gharavi S, Fooladi AAI, Alitappeh MA, ...
  • Qasemi A, Lagzian M, Rahimi F, Majd FK, Bayat Z. ...
  • Sharma P, Das S, Sadhu P, Pal S, Mitra S, ...
  • Chen Y-C, Lee W-C, Chuang Y-C. Emerging non-antibiotic options targeting ...
  • Bustamante M, Oomah BD, Oliveira WP, Burgos-Díaz C, Rubilar M, ...
  • Akgül T, Karakan T. The role of probiotics in women ...
  • Bustamante M, Oomah BD, Oliveira WP, Burgos-Díaz C, Rubilar M, ...
  • Shahbazi S, Habibi M, Badmasti F, Sabzi S, Farokhi M, ...
  • Shahbazi S, Karam MRA, Habibi M, Talebi A, Bouzari S. ...
  • Gupta V, Nag D, Garg P. Recurrent urinary tract infections ...
  • Zommiti M, Chikindas ML, Ferchichi M. Probiotics—live biotherapeutics: a story ...
  • Jeong J-J, Park HJ, Cha MG, Park E, Won S-M, ...
  • Shokryazdan P, Sieo CC, Kalavathy R, Liang JB, Alitheen NB, ...
  • Choi A-R, Patra JK, Kim WJ, Kang S-S. Antagonistic activities ...
  • Vagios S, Hesham H, Mitchell C. Understanding the potential of ...
  • Miglani R, Parveen N, Kumar A, Dewali S, Rawat G, ...
  • Petricevic L, Rosicky I, Kiss H, Janjic N, Kaufmann U, ...
  • Tommasi C, Equitani F, Masala M, Ballardini M, Favaro M, ...
  • Ng QX, Peters C, Venkatanarayanan N, Goh YY, Ho CYX, ...
  • Webster G, Blazejak A, Cragg BA, Schippers A, Sass H, ...
  • Asadpour L, Nahavandinejhad M. Frequency of Extended Spectrum Beta Lactamase ...
  • Saadatzadeh A FM, Jamalifar H, Dinarvand R. Probiotic Properties of ...
  • Abdelhalim MM, Saafan GS, El-Sayed HS, Ghaith DM. In vitro ...
  • Shivaee A, Shahbazi S, Soltani A, Ahadi E. Evaluation of ...
  • Goodarzi NN, Fereshteh S, Sabzi S, Shahbazi S, Badmasti F. ...
  • Shivaee A, Mirshekar M, Mohammadzadeh R, Shahbazi S. Association between ...
  • Shahbazi S, Badmasti F, Habibi M, Sabzi S, Noori Goodarzi ...
  • Taati Moghadam M, Mirzaei M, Fazel Tehrani Moghaddam M, Babakhani ...
  • Shivaee A, Meskini M, Shahbazi S, Zargar M. Prevalence of ...
  • Rastogi S, Singh A, Nandi A, Gupta A, Agarwal J, ...
  • Ali MS, Lee E-B, Hsu WH, Suk K, Sayem SAJ, ...
  • Chen C-C, Lai C-C, Huang H-L, Huang W-Y, Toh H-S, ...
  • Moglad EH. Antibiotics profile, prevalence of extended-spectrum beta-lactamase (ESBL), and ...
  • Bandari S, Arbab Soleimani N, Tajbakhsh E. The effect of ...
  • نمایش کامل مراجع